Protara Therapeutics, Inc. (TARA)
NASDAQ·Healthcare·Biotechnology
$5.06
+1.30%
Mkt Cap $192.56M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | — | — | — | -$0.32 | -$0.37 | -15.62% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.39 | -$0.31 | +20.51% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.43 | -$0.35 | +18.60% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.47 | -$0.29 | +38.30% | — | — |
| Q1 2025 Mar 5, 2025 | — | — | — | -$0.57 | -$0.48 | +15.79% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.50 | -$0.50 | +0.00% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.82 | -$0.45 | +45.12% | — | — |
| Q2 2024 May 2, 2024 | — | — | — | -$0.99 | -$0.97 | +2.02% | — | — |
| Q1 2024 Mar 13, 2024 | — | $1.21M | — | -$1.03 | -$0.90 | +12.62% | — | — |
| Q4 2023 Nov 3, 2023 | — | — | — | -$1.10 | -$0.87 | +20.91% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.97 | -$1.00 | -3.09% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$1.00 | -$0.80 | +20.00% | — | — |
| Q1 2023 Mar 8, 2023 | — | — | — | -$0.77 | -$0.84 | -9.09% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.85 | -$0.68 | +20.00% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$1.13 | -$0.80 | +29.20% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$1.09 | -$0.96 | +11.93% | — | — |
| Q1 2022 Mar 9, 2022 | — | — | — | -$0.94 | -$0.91 | +3.19% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$1.15 | -$0.96 | +16.52% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$1.14 | -$1.14 | +0.00% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.92 | -$1.20 | -30.43% | — | — |